Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Salah-Eddin Al-Batran, FLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Ramucirumab and the tag subtype-page.
Shares Oxaliplatin, Trastuzumab, Trastuzumab deruxtecan, Capecitabine and the tag subtype-page.
Shares HER2 ISH amplified (ERBB2 gene amplification), HER2 IHC 3+ (HER2-positive by immunohistochemistry), Zanidatamab, Trastuzumab and the tag subtype-page.
Shares HER2 IHC 2+ (equivocal, reflex to ISH), Disitamab vedotin, Trastuzumab, Trastuzumab deruxtecan and the tag subtype-page.
Shares Trastuzumab, Trastuzumab deruxtecan, Capecitabine, Paclitaxel / nab-paclitaxel and the tag subtype-page.
Shares Trastuzumab, Trastuzumab deruxtecan, HER2, Paclitaxel / nab-paclitaxel and the tag subtype-page.
Shares PD-L1 CPS (combined positive score), Fluorouracil (5-FU), Paclitaxel / nab-paclitaxel, Cisplatin and the tag subtype-page.
Shares Zanidatamab, Trastuzumab, Trastuzumab deruxtecan, Capecitabine and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.